EM PGY2 ✅
So thankful for all of the amazing & supportive pharmacists (esp. @EM_RxPert), nurses & providers that I’ve learned from over the last year - CCAG will always have a place in my heart 🥹❤️
Time to move to TN, have a baby and start my career as an EM Specialist 😅🥳
As I wrap up the end of PGY2, I’m feeling very grateful for the opportunity to have attended the first @SAEM_AEMP in AZ with my @CleClinicRxRes pals last month 🚑🚨
Always so fun catching up with @NKCHRxResidency friends too 🤩
Beyond excited to be able to share my PGY1 research project results at @SCCM this year ☺️
Thankful for such a supportive team that helped to make it happen! @NKCHRxResidency @memusselman @jmc_cardspharmd
🚨 Interested in an EM PGY2? 🚨
Come meet with us during PPS-like interviews 12/4-12/7 (sign up below) or during our on-site open house on 12/14!
CCAG really has it all (including preceptors willing to snap 100 shots on the helipad to get the perfect one for Twitter) 🤗
Register today for the 2023 Fall OCCP Meeting on Friday, Nov 17th! Meeting includes Ohio Law Review CE by Dr. Donnie Sullivan, clinical pearls, afternoon tracks for preceptors & trainees, and a PGY-2 residency showcase! Visit https://t.co/KsYFshsKrs to learn more and register!
Let's talk about choice of RSI agent in patients with sepsis. Overall, there was no difference in 28 day mortality in patients who received etomidate or ketamine for RSI. Patients who received etomidate were more likely to require vasopressors within 3 hours of RSI. @jessbpharmd
Cheers to a great first year of residency and to the people that made it possible. Thankful & grateful don’t even begin to describe it. @NKCHRxResidency
Up next: EM PGY-2!!!
#TwitteRx#PharmRes